{"entity":{"type":"insider","cik":"0001569821","url":"/insider/0001569821","json_url":"/insider/0001569821.json","name":"OrbiMed Israel BioFund GP Limited Partnership","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":14,"first":"2019-05-06","last":"2026-04-09","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Israel BioFund GP Limited Partnership","source":"filing","n_filings":14,"first_seen":"2019-05-06","last_seen":"2026-04-09"}],"transactions":[{"id":5901684,"accession":"0000947871-26-000421","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72939.0,"shares_display":"72,939","price_per_share":6.417444576975281,"price_display":"6.42","price_state":"stated","total_value":468081.99,"total_display":"468,081.99","total_whole":"468,082","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider","n_lines":2},{"id":5901680,"accession":"0000947871-26-000421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31719.0,"shares_display":"31,719","price_per_share":6.5186503357609,"price_display":"6.52","price_state":"stated","total_value":206765.07,"total_display":"206,765.07","total_whole":"206,765","shares_owned_after":34923.0,"shares_owned_after_display":"34,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider","n_lines":2},{"id":4523966,"accession":"0000947871-25-000898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000898","line_url":"/filing/0000947871-25-000898","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Capital GP V LLC; OrbiMed Israel GP II, L.P.; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000000.0,"shares_display":"5,000,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":4490254.0,"shares_owned_after_display":"4,490,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider","n_lines":2},{"id":2107828,"accession":"0000947871-24-000498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000498","line_url":"/filing/0000947871-24-000498#line-1","is_derivative":false,"issuer_cik":"0001282930","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001282930","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; GORDON CARL L; OrbiMed Israel BioFund GP Limited Partnership; Chimovits Erez","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24344.0,"shares_display":"24,344","price_per_share":0.3812,"price_display":"0.38","price_state":"stated","total_value":9279.9328,"total_display":"9,279.93","total_whole":"9,280","shares_owned_after":13773653.0,"shares_owned_after_display":"13,773,653","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-20","scope":"insider"},{"id":2340772,"accession":"0000950170-24-008053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-008053","line_url":"/filing/0000950170-24-008053","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Capital GP V LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP II, L.P.; OrbiMed Israel GP Ltd.","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3125000.0,"shares_display":"3,125,000","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","total_whole":"7,500,000","shares_owned_after":7526359.0,"shares_owned_after_display":"7,526,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-26","scope":"insider","n_lines":3},{"id":8620728,"accession":"0000947871-23-000713","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-23-000713","line_url":"/filing/0000947871-23-000713","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Israel GP II, L.P.; OrbiMed Israel BioFund GP Limited Partnership; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; Chimovits Erez; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Israel GP II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":875000.0,"shares_display":"875,000","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":1828750.0,"total_display":"1,828,750.00","total_whole":"1,828,750","shares_owned_after":5685259.0,"shares_owned_after_display":"5,685,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider","n_lines":4},{"id":8310413,"accession":"0000947871-23-000336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-23-000336","line_url":"/filing/0000947871-23-000336#line-1","is_derivative":false,"issuer_cik":"0001282930","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001282930","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership; Chimovits Erez; GORDON CARL L","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":348000.0,"shares_display":"348,000","price_per_share":0.245,"price_display":"0.24","price_state":"stated","total_value":85260.0,"total_display":"85,260.00","total_whole":"85,260","shares_owned_after":3161489.0,"shares_owned_after_display":"3,161,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-17","scope":"insider"},{"id":8064284,"accession":"0000947871-23-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-23-000015","line_url":"/filing/0000947871-23-000015","is_derivative":false,"issuer_cik":"0001534248","issuer_name":"Chemomab Therapeutics Ltd.","issuer_ticker":"CMMB","issuer_name_source":null,"issuer_url":"/issuer/0001534248","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"American Depository Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":336900.0,"shares_display":"336,900","price_per_share":3.584918610863758,"price_display":"3.58","price_state":"stated","total_value":1207759.08,"total_display":"1,207,759.08","total_whole":"1,207,759","shares_owned_after":2311798.0,"shares_owned_after_display":"2,311,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider","n_lines":2},{"id":4454131,"accession":"0000947871-21-000844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-21-000844","line_url":"/filing/0000947871-21-000844#line-1","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2813489.0,"shares_owned_after_display":"2,813,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-30","scope":"insider"},{"id":4269331,"accession":"0000947871-21-000712","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-21-000712","line_url":"/filing/0000947871-21-000712#line-3","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15989876.0,"shares_display":"15,989,876","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":19347749.96,"total_display":"19,347,749.96","total_whole":"19,347,750","shares_owned_after":8565974.0,"shares_owned_after_display":"8,565,974","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-25","scope":"insider"},{"id":4269328,"accession":"0000947871-21-000712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-21-000712","line_url":"/filing/0000947871-21-000712#line-2","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":319255.0,"shares_display":"319,255","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":440571.9,"total_display":"440,571.90","total_whole":"440,572","shares_owned_after":24555850.0,"shares_owned_after_display":"24,555,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-25","scope":"insider"},{"id":4269325,"accession":"0000947871-21-000712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-21-000712","line_url":"/filing/0000947871-21-000712#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"9 METERS BIOPHARMA, INC.","issuer_ticker":"NMTR","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":841650.0,"shares_display":"841,650","price_per_share":1.36,"price_display":"1.36","price_state":"stated","total_value":1144644.0,"total_display":"1,144,644.00","total_whole":"1,144,644","shares_owned_after":24875105.0,"shares_owned_after_display":"24,875,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-23","filed_date":"2021-06-25","scope":"insider"},{"id":3205029,"accession":"0000947871-20-000933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-20-000933","line_url":"/filing/0000947871-20-000933#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103200.0,"shares_display":"103,200","price_per_share":21.6,"price_display":"21.60","price_state":"stated","total_value":2229120.0,"total_display":"2,229,120.00","total_whole":"2,229,120","shares_owned_after":73650.0,"shares_owned_after_display":"73,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-04","scope":"insider"},{"id":7859307,"accession":"0000947871-19-000983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-19-000983","line_url":"/filing/0000947871-19-000983#line-2","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":8.9,"price_display":"8.90","price_state":"stated","total_value":31150.0,"total_display":"31,150.00","total_whole":"31,150","shares_owned_after":2313489.0,"shares_owned_after_display":"2,313,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider"},{"id":7859305,"accession":"0000947871-19-000983","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000983","line_url":"/filing/0000947871-19-000983#line-1","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.93,"price_display":"8.93","price_state":"stated","total_value":4465.0,"total_display":"4,465.00","total_whole":"4,465","shares_owned_after":2309989.0,"shares_owned_after_display":"2,309,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"},{"id":7832371,"accession":"0000947871-19-000961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-19-000961","line_url":"/filing/0000947871-19-000961#line-2","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5400.0,"shares_display":"5,400","price_per_share":8.92,"price_display":"8.92","price_state":"stated","total_value":48168.0,"total_display":"48,168.00","total_whole":"48,168","shares_owned_after":2309489.0,"shares_owned_after_display":"2,309,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-12","scope":"insider"},{"id":7832366,"accession":"0000947871-19-000961","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000961","line_url":"/filing/0000947871-19-000961#line-1","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3400.0,"shares_display":"3,400","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":29750.0,"total_display":"29,750.00","total_whole":"29,750","shares_owned_after":2304089.0,"shares_owned_after_display":"2,304,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-12","scope":"insider"},{"id":7859302,"accession":"0000947871-19-000948","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-19-000948","line_url":"/filing/0000947871-19-000948#line-3","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":8.68,"price_display":"8.68","price_state":"stated","total_value":52080.0,"total_display":"52,080.00","total_whole":"52,080","shares_owned_after":2300689.0,"shares_owned_after_display":"2,300,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-09","scope":"insider"},{"id":7859299,"accession":"0000947871-19-000948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-19-000948","line_url":"/filing/0000947871-19-000948#line-2","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":6400.0,"total_display":"6,400.00","total_whole":"6,400","shares_owned_after":2294689.0,"shares_owned_after_display":"2,294,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-09","scope":"insider"},{"id":7859295,"accession":"0000947871-19-000948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000948","line_url":"/filing/0000947871-19-000948#line-1","is_derivative":false,"issuer_cik":"0001569590","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001569590","owner_cik":null,"owner_name":"OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Israel BioFund GP Limited Partnership","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3400.0,"shares_display":"3,400","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":27166.0,"total_display":"27,166.00","total_whole":"27,166","shares_owned_after":2293889.0,"shares_owned_after_display":"2,293,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-09","scope":"insider"},{"id":8377947,"accession":"0000947871-19-000337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000337","line_url":"/filing/0000947871-19-000337#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":646204.0,"shares_display":"646,204","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":2003232.4,"total_display":"2,003,232.40","total_whole":"2,003,232","shares_owned_after":3183314.0,"shares_owned_after_display":"3,183,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-02","filed_date":"2019-05-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2023-06-29","last_seen":"2026-04-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001739174","name":"BiomX Inc.","url":"/issuer/0001739174","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2019-12-09","last_seen":"2024-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001534248","name":"Chemomab Therapeutics Ltd.","url":"/issuer/0001534248","role":"Ten percent owner","n_filings":1,"first_seen":"2023-01-05","last_seen":"2023-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001551986","name":"9 METERS BIOPHARMA, INC.","url":"/issuer/0001551986","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-25","last_seen":"2021-06-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Novus Therapeutics, Inc.","url":"/issuer/0001404281","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2019-05-06","last_seen":"2020-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001569821","retrieved_at":"2026-08-26T00:47:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}